The Claim
In adults with irritable bowel syndrome, approximately 70% of those receiving open-label placebo achieve a clinically meaningful 50-point reduction in IBS Severity Scoring System scores.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Among adults with irritable bowel syndrome who are told they are receiving a placebo, about 70% experience a 50-point drop in symptom severity scores on a standardized scale.
See the scientific wording
In adults with irritable bowel syndrome, approximately 70% of those receiving open-label placebo achieve a clinically meaningful 50-point reduction in IBS Severity Scoring System scores, indicating that open-label placebo may be a viable therapeutic option for a substantial proportion of patients with refractory symptoms.
When a person expects relief from a treatment, even if they know it's a sugar pill, their brain triggers natural pain-relieving chemicals and calms signals from the gut, which reduces abdominal discomfort and bowel problems.
What the research says
1 studyStudy: Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial
In a study, people with IBS who were told they were taking a sugar pill (but still got better) had about the same improvement as those who didn’t know if it was real medicine or not — about 7 out of 10 felt much better. So even when you know it’s a placebo, it can still help.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.